TrialGynecologic oncology2024

Results of a randomized phase II trial of paclitaxel and carboplatin versus bleomycin, etoposide and cisplatin for newly diagnosed and recurrent Chemonaive stromal ovarian tumors: An NRG oncology/gynecologic oncology group study14.

Jubilee Brown et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.